business of Pharmaceutical companies:- Pharmaceutical companies are not especially big in terms of revenues‚ but they are very profitable. For instance‚ in 2001‚ Pfizer was ranked 127th in the world on total revenue (US$32·2 billion) but 7th in terms of profit.29 The pharmaceutical industry is the most profitable business sector‚ with an average 16·2% profit‚ ahead of financial companies (11·6%) and beverages (10%).30 However‚ net income growth has declined‚ and growth in the value of drug
Premium Pharmacology Profit Income
Questions for Review 1. Pharmaceutical companies do have a responsibility to distribute drugs for a low cost in developing and poorer countries. Africa’s GDP‚ and per capita income is very low so they cannot afford to buy top quality medicines. One main argument for this approach is the AIDS epidemic in Africa. A main argument against this is that the treatment for AIDS is very expensive to provide to a whole country for free. 2. The principal arguments of pharmaceutical companies that oppose making
Premium HIV World Trade Organization Pharmacology
Introduction: The BCG Matrix and the Product Life Cycle are two important tools that relate to different aspects of a product’s performance: • The BCG looks at market share and market growth and how they impact on cash usage and generation. • The PLC looks at sales/revenues over time and levels of profitability. Boston Consulting Group (BCG) Matrix Businesses must keep their product offerings relevant and profitable to stay in operation. The Boston Consulting Group developed a tool‚ called the BCG matrix
Premium Marketing Product management Management
BOSTON CONSULTING GROUP MATRIX ( BCG ) This technique is particularly useful for multi-divisional or multiproduct companies. The divisions or products compromise the organisations “business portfolio”. The composition of the portfolio can be critical to the growth and success of the company. The BCG matrix considers two variables‚ namely.. N MARKET GROWTH RATE N RELATIVE MARKET SHARE The market growth rate is shown on the vertical (y) axis and is expressed as a %. The range is set somewhat
Premium Strategic management Marketing Product management
Table of Contents Introduction: 1 Bangladeshi Pharmaceutical Industry: 2 Industry Analysis: 2 Competitive Force 1: Rivalry among Existing Firms 3 Competitive Force 2: Threat of New Entrants 3 Competitive Force 3: Threat of Substitute Products 3 Competitive Force 4: Bargaining Power of Buyers 4 Competitive Force 5: Bargaining Power of Suppliers 4 Competitive Strategy Analysis: 5 Cost Leadership: 5 Product Differentiation: 5 Corporate Strategy Analysis: 6 Conclusion:………………………………………………………………………………………………………7
Premium Generic drug Pharmacology Pharmaceutical industry
interview of some manager of Square Pharmaceuticals Ltd. 1.4 Methodology • The entire report was dependent solely on secondary data‚ taken from the annual report of Square Pharmaceuticals Ltd. and books. • Some primary data were obtained by interview. 1.5 Limitations The limitations to produce this report are as follows:- • The accuracy of the report depends upon the accuracy of the information furnished by our text book and from annual report of Square Pharmaceuticals Ltd. as well. • Inadequate
Premium Strategic management Corporation Marketing
CORPORATE SOCIAL PRACTICES IN BANGLADESH: A STUDY ON PHARMACEUTICAL SECTORS IN BANGLADESH. Report On CORPORATE SOCIAL PRACTICES IN BANGLADESH: A STUDY ON PHARMACEUTICAL SECTORS IN BANGLADESH. Course Code: BUS-498 Submitted to: Md. Jahirul Islam Lecturer‚ ASAUB Submitted by: Farhana Bhuiyan ID# 073-12-0020 BBA 3rd Batch‚ ASAUB [pic] ASA UNIVERSITY BANGLADESH December‚ 2011 Declaration of originality
Premium Corporate social responsibility
The company I chose to conduct my BCG Matrix on was Wal-Mart‚ because this company has become one of the largest and most successful companies within the United States. Wal-Mart started out as a small retail business in 1962 in Rogers‚ Arkansas by Sam Walton. Today Wal-Mart has more than 10‚000 stores in more than twenty eight different countries. In 2012 Wal-Mart gained revenue of $421‚849 million dollars‚ which was an increase of 3.4% from the previous year. (www.topics.nytimes.com>Business>Companies
Premium Wal-Mart
To begin with‚ BCG is the acronym for Boston Consulting Group—a general management consulting firm highly respected in business strategy consulting. BCG Growth-Share Matrix (see figure 1) happens to be one of many of BCG’s strategic concepts the organisation developed in the late 1970s‚ and is being taught at leading business schools and executive education programmes around the world. It is a management tool that serves four distinct purposes (McDonald 2003; Kotler 2003; Cipher 2006): it can
Premium Strategic management Management consulting Management
PHARMACEUTICAL INDUSTRY ANALYSIS Industry Background: The total industry can broadly be classified into two categories. These are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production. Generic
Premium Pharmaceutical industry Pharmacology